• Leonardo Lorente, María M Martín, Ester López-Gallardo, José Ferreres, Jordi Solé-Violán, Lorenzo Labarta, César Díaz, Alejandro Jiménez, Julio Montoya, and Eduardo Ruiz-Pesini.
• Intensive Care Unit, Hospital Universitario de Canarias, Ofra, s/n, La Laguna-38320, Santa Cruz de Tenerife, Spain. Electronic address: lorentemartin@msn.com.
• J Crit Care. 2016 Jun 1; 33: 95-9.

ObjectiveThe influence of mitochondrial deoxyribonucleic acid (mtDNA) haplogroup or oxidative phosphorylation system (OXPHOS) function on survival of septic patients has been scarcely studied. However, the association between mtDNA haplogroup, OXPHOS capacity at diagnosis of severe sepsis, and survival has been not previously reported, and that was the objective of the present study.MethodsThis was a prospective, multicenter, observational study. Blood samples from 198 patients at diagnosis of severe sepsis were analyzed to determine mtDNA haplogroup and platelet respiratory complex IV (CIV) specific activity. The end point of the study was 30-day survival.ResultsSeptic patients with mtDNA haplogroup JT showed higher 30-day survival than those with mtDNA haplogroup non-JT (31/38 [81.6%] vs 99/160 [61.9%]; P= .02). Septic patients with mtDNA haplogroup JT showed higher platelet CIV specific activity than those with mtDNA haplogroup non-JT (P= .002).ConclusionsThe main novel finding of our study, including the largest series providing data on platelet CIV specific activity according to mtDNA haplogroup in severe septic patients, was that those with mtDNA haplogroup JT showed higher survival and higher platelet CIV specific activity at diagnosis of severe sepsis than patients with mtDNA haplogroup non-JT.Copyright © 2016 Elsevier Inc. All rights reserved.

6 keywords...

hide…